Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value
The 150-year-old drugmaker is the first company in health care to hit the milestone.
Last updated: 2025-11-22 22:47:29 ET
No hourly mention data available.
The 150-year-old drugmaker is the first company in health care to hit the milestone.
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
A more than 35% rally in the company's stock this year has largely been driven by the explosive growth of the weight-loss drug market.
The pharmaceutical giant Eli Lilly's stock has been riding the skyrocketing demand for its weight loss injection Zepbound and diabetes treatment Mounj...
Eli Lilly on Friday briefly crossed the $1 trillion market-cap threshold, the first drugmaker to ever reach that milestone.
This former Eli Lilly exec just raised a $52 million seed round from family offices to build a new healthcare AI startup
The announcements come days after President Donald Trump struck deals with Novo Nordisk and Eli Lilly to make their GLP-1s easier for Americans to acc...
Melodee Buzzard's grandmother Lilly Denes was adopting the 9-year-old when she says mother Ashlee took her away in 2021, and now Santa Barbara Co...